Assessment of apoptosis in xenobiotic-induced immunotoxicity.
Generation of immunity is a highly complex process in which proliferation and differentiation of immune-competent cells regulated by cytokines and cell-cell interactions play a major role. Reducing the number of immune-competent cells or altering the function, selection, and differentiation of lymphocytes after xenobiotic treatment may lead to serious adverse effects. Programmed cell death, or apoptosis, is a highly regulated process by which an organism eliminates unwanted cells without eliciting an inflammatory response. However, xenobiotics are also able to trigger unwanted apoptosis or to alter the regulation of programmed cell death. Cytological characteristics of apoptosis are generally different from those seen in acute pathological cell death resulting from cell injury. The morphological characteristics of apoptosis are unique including cell shrinkage, membrane blebbing, chromatin condensation, DNA fragmentation, disruption of the nuclear lamina, nuclear fragmentation, and emergence of apoptotic bodies. It is now established that apoptosis plays a critical role in both development and homeostasis of the immune system: thymic selection, cytotoxicity, deletion of autoreactive cells, and regulation of the size of the lymphoid compartment. Assessment of apoptosis relies on the morphological and biochemical modifications of the dying cells. As a rule, and because an apoptotic cell rarely displays all of the characteristic apoptotic features, several criteria should be monitored in parallel including morphological examination. The techniques described in this paper have been divided into five categories: analysis of cell morphology by microscopy, identification of DNA fragmentation, determination of mitochondrial membrane potential, detection of plasma membrane changes, analysis of caspase activation.
Pallardy
M
M
INSERM U461, Faculté de Pharmacie Paris-Sud, rue JB Clément, Châtenay-Malabry, 92296, France. marc.pallardy@cep.u-psud.fr
Biola
A
A
Lebrec
H
H
Bréard
J
J
D000818:Animals; D017209:Apoptosis / Q000187:drug effects* / Q000276:immunology; D020169:Caspases / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D048429:Cell Size / Q000187:drug effects; D053938:DNA Fragmentation / Q000187:drug effects; D004587:Electrophoresis, Agar Gel; D005434:Flow Cytometry; D006801:Humans; D007107:Immune System / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D020287:In Situ Nick-End Labeling; D008564:Membrane Potentials; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D014116:Toxicology / Q000379:methods; D015262:Xenobiotics / Q000633:toxicity*
D015262:Xenobiotics; D020169:Caspases